EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION    
 
Services How to use the platform Build a poster MANAGE ORDERS FAQs Contact HOMEPAGE
 
 
   
Discussion forum - 49th ERA-EDTA Congress
    Topic - Renal development / Cystic diseases

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.

 

Poster: 11
Visits: 755
Title: Premature delivery triggers termination of nephrogenesis program which leads to reduced nephron number and hypertension
Authors: Ashraf El-Meanawy , V. Rufanova and C. Stelloh
Centre: Medical College of Wisconsin and Zablocki VA Medical Center

You must be registered to reply or comment.

PREMATURE DELIVERY TRIGGERS TERMINATION OF NEPHROGENESIS PROGRAM WHICH LEADS TO REDUCED NEPHRON NUMBER AND HYPERTENSION

Ashraf El-Meanawy
Thread initiator
Subspeciality
Reg: 5/10/2012 11:55:00 PM

Comment# 1

Premature delivery causes termination of nephrogenesis which lead to low nephron number, hypertension and proteinuria.

Comment added on 5/10/2012 11:55:00 PM 
     
You must be registered to reply or comment.




Most viewed poster for this congress
Poster: 424
Visits: 2636
Title: Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors: Giuseppe Coppolino ,
Centre: Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy


Poster most viewed in this topic
Poster: 2
Visits: 1203
Title: DELETIONS OF SIX1 AND UPK3A MAY CONTRIBUTE TO A RENAL PHENOTYPE IN SYNDROMAL PATIENTS
Authors: Albertien van Eerde , Ellen van Binsbergen1, Yvette Konijnenberg2, Merel C. Maiburg1, Klaske D. Lichtenbelt1, Peter G.J. Nikkels3, Jasper vd Smagt1, Kirsten Y.Renkema1, Jacques C. Giltay1, Tom P.V.M. de Jong2, Marc R. Lilien2, Nine V.A.M. Knoers1
Centre: UMC Utrecht, The Netherlands: 1 Department of Medical Genetics, 2 Paediatric Renal Center, 3 Department of Pathology


 View Poster Gallery
 Back to congress home
 Other Congresses


 
 
  About us  |  Terms and Conditions  |  Special Access